ArticleActa epileptologica2026
Predictors of cognitive impairment in drug-resistant epilepsy: the role of interictal EEG abnormalities.
Article in Acta epileptologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive impairment (CI) affects approximately one-third of patients with drug-resistant epilepsy (DRE), underscoring the need for accessible predictors. Interictal electroencephalographic (EEG) abnormalities have been proposed as potential indicators of cognitive dysfunction; however, their independent diagnostic utility is unclear. This study aimed to investigate the association between interictal EEG patterns and CI in adults with DRE, with a specific focus on evaluating their incremental predictive value beyond established clinical predictors.
methodsIn this cross-sectional study of 90 adults with DRE were recruited over a six-month period. Participants were stratified into two groups based on their Montreal Cognitive Assessment (MoCA): those with cognitive impairment (Cases; n = 45; MoCA < 26) and those with preserved cognition (Controls; n = 45; MoCA ≥ 26). All participants underwent routine interictal scalp EEG, An EEG recording was classified as abnormal if epileptiform discharges or significant background slowing was identified. The relationships between cognitive status and various clinical variables-including age, monthly seizure frequency and epilepsy type were analyzed using multivariable logistic regression, with expressed as odds ratios alongside their 95% confidence intervals.
resultsThe frequency of monthly seizures was significantly higher in the CI group compared to the control group (9.6 ± 2.8 vs. 5.4 ± 2.1 seizures/month, P < 0.001). Interictal EEG abnormalities were also more prevalant in CI group (77.8% vs. 57.8%; OR = 2.56, 95% CI: 1.02-6.41, P = 0.041). However, in the adjusted multivariable model, only seizure frequency reained a signifcant independent association with CI (adjusted OR = 0.46, 95% CI: 0.32-0.65, P < 0.001), indicating that EEG abnormalities did not confer significant additional predictive power after accounting for seizure burden.
conclusionsSeizure burden emerged as the predominant predictor of CI with DRE, while interictal EEG abnormalities demonstrated a univariate correlation with cogntive status, this association was not independent in the adjusted analysis. EEG findings may still provide contextual or supportive clinical context, emphasize that a comprehensive approach integrating seizure management with cognitive assessments is warranted, rather than relying primarily on interictal EEG for cognitive risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.